2000
DOI: 10.1038/modpathol.3880243
|View full text |Cite
|
Sign up to set email alerts
|

Expression of the Tumor Necrosis Factor Receptor-Associated Factors (TRAFs) 1 and 2 is a Characteristic Feature of Hodgkin and Reed-Sternberg Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
19
0

Year Published

2001
2001
2011
2011

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(23 citation statements)
references
References 40 publications
4
19
0
Order By: Relevance
“…35 Although future studies are required to elucidate the precise mechanisms governing deregulation of these survival pathways in pediatric ALL, the role of other TRAF members in drug resistance has been suggested in several types of cancers, including B-cell chronic lymphoblastic leukemia (B-CLL) and Hodgkin disease. [47][48][49] We found that prolonged PARP1 activity contributed to the increase in NF-B transcriptional activity. Consequently, inhibiting PARP1 activity abolished NF-B DNA binding, leading to the down-regulation of its target proteins, cIAP1 and TRAF6, events that would facilitate p53-dependent apoptosis.…”
Section: Discussionmentioning
confidence: 87%
“…35 Although future studies are required to elucidate the precise mechanisms governing deregulation of these survival pathways in pediatric ALL, the role of other TRAF members in drug resistance has been suggested in several types of cancers, including B-cell chronic lymphoblastic leukemia (B-CLL) and Hodgkin disease. [47][48][49] We found that prolonged PARP1 activity contributed to the increase in NF-B transcriptional activity. Consequently, inhibiting PARP1 activity abolished NF-B DNA binding, leading to the down-regulation of its target proteins, cIAP1 and TRAF6, events that would facilitate p53-dependent apoptosis.…”
Section: Discussionmentioning
confidence: 87%
“…Constitutive upregulation of NF-kB has recently been correlated with progression of breast cancer, melanoma, and juvenile myelomonocytic leukemia (Kochetkova et al, 1997;Nakshatri et al, 1997;Raziuddin et al, 1997;Izban et al, 2000). How NF-kB is constitutively up-regulated in some tumor cells and what role it plays in acquiring resistance to apoptosis is not clear.…”
Section: Introductionmentioning
confidence: 99%
“…AraC potentiates cis-platin-, etoposide-, or taxolmediated cytotoxicity in SA-LPS/Jkt and HuT-78 cells NF-kB is known as an antiapoptotic factor (Kochetkova et al, 1997;Nakshatri et al, 1997;Raziuddin et al, 1997;Izban et al, 2000). In order to detect the role of NF-kB on cell viability, HuT-78 or SA-LPS/Jkt cells were incubated with 10 mm each of cis-platin, vincristine, doxorubicin, etoposide, adriamycin, or taxol and 50 mm of araC for 72 h and MTTassayed.…”
Section: Arac Induces Protein Phosphatases 2a and 2b-a Which Dephospmentioning
confidence: 99%
“…For example, upregulation of TRAF1 has consistently been reported in lymphoid malignancies (Zapata et al, 2000;Durkop et al, 1999;Izban et al, 2000), with increased expression of TRAF1 in Epstein-Barr virus-transformed lymphoid cells and Reed-Sternberg cells in Hodgkin's disease.…”
Section: Tissue Expression Of Traf Proteinsmentioning
confidence: 99%